3Mcore KP.Wong F,Gines P, et al. The management of aseites in cirrhosis:report on the consensus conference of the international ascites club. Hepatology, 2003,8 : 258-266.
4Ferenci P,lockwood AH, Mullen KD, et al. Hepatic encephalopathydenfinition nomenclat ure, diagnosis, and quanificat ion : final report of the working party at the 11th Word Congress of Gastroenterology, Vienna, 1998. Hepatology, 2002,35 : 716-721.
5陈灏珠.实用内科学[M].北京:人民卫生出版社,2002.1729-1731.
6Lisa M, Forman M. Michael R, et al, Predicting the prognosis of chronic liver disease: An evolution from Child to MELD. Hepatology,2001 ,33:473-475.
7Ruf AE, Kremers WK, Chavez LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortaliity better than MELD alone,Liver Transpl,2005,11:336-343.
8Porcel A, Diaz F, Rendon P, et al. Dilutional hyponatremia in patienls with cirrhosis and ascites. Arch Intern Med,2002,162:323- 328.
9Angeli P,Wong F,Watson H,et al. Hyponatremia in cirrhosis: results of a patient population survey. Hepatology, 2006, 44:1535-1542.
10Haussinger D. l.ow grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology, 2006,43:1187-1190.
2Porcei A, Diaz F, Rendon P, et al. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med,2002,162:323 - 328.
3Ruf AE, Kremers WK, Chavez LL, et al. Addition of serum sodium into the MELD score prediets waiting list mortality better than MELD alone. Liver Transpl,2005 ,11:336 - 343.
